AKAP12 and colorectal carcinoma: Similarly, according to GSE64472 and GSE19862, a tendency towards elevated levels of AKAP12 was also observed in cediranib-resistant NSCLC (Supplementary Figure S1A) and BV non-responding CRC (Supplementary Figure S1B).